FARMACOSMO S.P.A. PRESS RELEASE
FARMACOSMO: NOTICE OF CHANGE IN SHARE CAPITAL FOLLOWING
THE BONUS SHARE ASSIGNMENT
Naples, May 18th 2023
Farmacosmo S.p.A. ("Company", "Farmacosmo"), a company active in the Health, Pharma & Beauty sector, listed on the Euronext Growth Milan market of Borsa Italiana, announces that the free assignment of 1,216,195 ordinary shares of Farmacosmo S.p.A. was concluded today. Please note that, as specified in the Admission Document, the Bonus Share mechanism provides for an increase in the number of shares issued without any disbursement by the beneficiaries, establishing that such shares are assigned in the ratio of no. 1 bonus share for every no. 5 shares subscribed and/or purchased in the context of the Placing, provided that the uninterrupted retention of full ownership of the shares subscribed for and/or purchased in the context of the offer the offer at least until the end of the twelfth calendar month following the date of the commencement of trading (i.e. up to and including 30 March 2023).
For the purpose of the free Bonus Share allotment, the Company announces that 1,216,195 ordinary Farmacosmo shares were issued in execution of the free capital increase resolved by the Shareholders' Meeting of the Company on 2 March 2022 (the "Capital Increase") to service the Bonus Share mechanism.
In consideration of the issuance of the aforementioned shares, in execution of the bonus share capital increase, the following is the new composition of the share capital (fully subscribed and paid-in), as it will result following the registration of the variation certificate filed today with the competent Company Registry pursuant to Article 2444 of the Italian Civil Code:
CURRENT SHARE CAPITAL | PREVIOUS SHARE CAPITAL | VARIATION | ||||||||
Euro | n. of | Nominal | Euro | n. of | Nominal | Euro | n. of | Nominal | ||
Shares | Unit | Shares | Unit | Shares | Unit | |||||
Value | Value | Value | ||||||||
Total | 3.480.502,67 | 38.857.840 | Shares | 3.008.610,50 | 37.641.645 | Shares | 471.892,17 | 1.216.195 | Shares | |
of which: | without | without | without | |||||||
Ordinary | 3.153.380,96 | 34.762.775 | nominal | 2.681.488,79 | 33.546.580 | nominal | 471.892,17 | 1.216.195 | nominal | |
shares | value | value | value | |||||||
Multiple- | 327.121,71 | 4.095.065 | 327.121,71 | 4.095.065 | - | - | ||||
vote | ||||||||||
shares* |
- Owned by the shareholder DECO F S.r.l.. These shares, which grant 3 voting rights each, are not admitted for trading on Euronext Growth Milan.
Following the free assignment of the above-mentioned Bonus Shares, the Company - pursuant to Article 26 of the Euronext Growth Milan Issuers' Regulations - announces that, according to the latest results in its possession, the shareholding structure is composed as follows:
Shareolder | No. of ordinary | No. of shares with | Total no. of | % on ordinary | % of share | % of voting rights |
shares | multiple voting rights | shares | shares | capital | ||
DECO F S.r.l. (1) | 10.905.373 | 4.095.065 | 15.000.43 | 31,37% | 38,60% | 49,29% |
Fabio de Concilio (2) | 847.545 | - | 847.545 | 2.44% | 2,18% | 1,80% |
Francesco de Concilio (3) | 66.476 | - | 66.476 | 0,19% | 0,17% | 0,14% |
VAR S.r.l. (4) | 4.925.287 | - | 4.925.287 | 14,17% | 12,68% | 10,47% |
FARVIMA Medicinali S.p.A. (5) | 2.700.000 | - | 2.700.000 | 7,77% | 6,95% | 5,74% |
Fulvio Bartoli (6) | 3.019.556 | - | 3.019.556 | 8,69% | 7,77% | 6,42% |
Marco Piccolo (7) | 1.278.315 | - | 1.278.315 | 3,68% | 3,29% | 2,72% |
Dario Cusani (8) | 732.328 | - | 732.328 | 2,11% | 1,88% | 1,56% |
PRESS RELEASE
Mercato | 10.287.895 | - | 10.287.895 | 29,59% | 26,48% | 21,87% |
Totale | 34.762.775 | - | 38.857.840 | 100% | 100% | 100% |
- Shareholder subject to lock-up restriction for the amount indicated in the table
- Shareholder subject to lock-up for the amount indicated in the table.
- Shareholder subject to lock-up for the amount indicated in the table
- Shareholders subject to lock-up for a number of shares equal to 4,883,141
- Shareholder subject to lock-up for the amount indicated in the table
- Shareholders subject to lock-up for a number of shares equal to 2,929,721
- Shareholders subject to a lock-up obligation for a number of shares equal to 1,220,683
- Shareholders subject to lock-up for the amount indicated in the table
***
This press release is available on the www.farmacosmoinvestors.comwebsite, section "Investors/Press Releases" and on the authorized storage mechanism "eMarket Storage" (www.emarketstorage.com)."
***
THE SOCIETY
Farmacosmo is a company active in the Health, Pharma & Beauty sectors. The company's business model is based on the circular model of the l(ea)n strategy, and is divided into three main business areas: Logistics, Intelligence and Node. Logistics: enables the management and fulfillment of up to 12,000 orders per day, with delivery times of up to 20 hours from carrier picking and just-in time procurement ('zero warehouse' policy). Intelligence: includes strategy definition, competitive positioning and customer journey activities, which enabled the company to intercept c. 188,000 customers in 2021. Recurring customers contributed 74% of the annual retail stream turnover. The average cart value of active customers in the retail stream amounted to €92 (€109 related to recurring customers). Node: R&D activities, process innovation and IT infrastructure of the company. Over the past five years, Farmacosmo's sales value has grown by 54% (CAGR 2016-2021) and will be around €58 million in 2021. The Farmacosmo ecosystem aims to pursue standards of excellence in every part of its value chain, being inspired by compliance with ESG principles at all stages of the logistics process (from the packaging used for online orders to carbon compensation initiatives) and in the valorisation of its employees, the company's strategic asset. The portals ProfumeriaWeb, Phàrmasi, Bau Cosmesi and ContactU, an innovative platform of telepsychology launched in March 2023, are part of Farmacosmo Group. During 2022, Farmacosmo launched its rooting strategy through the acquisition of Farmacosmo-branded logistics pharmacies. Farmacosmo's commitment to ESG is also underlined by the publication of its Sustainability Report 2021.
IDENTIFICATION CODES
Ordinary Share: ISIN IT0005487670 (Ticker COSMO)
Warrant Farmacosmo 2022-2025: ISIN IT0005487415 (Ticker WCOSMO)
FOR FURTHER INFORMATIONS: | ||
INVESTOR RELATIONS MANAGER | EURONEXT GROWTH ADVISOR | INVESTOR & MEDIA RELATION |
ADVISOR | ||
Farmacosmo | Illimity Bank | |
Farmacosmo | ||
Via Crispi, 51 - 80121 Napoli | Via Soperga, 9 - 20124 Milano | |
Via Bigli, 19 - 20121 Milano | ||
Tel. +39 02 82849699 | ||
Tel. +39 02 50042143 | Tel +39 02 45473883 | |
Pietro Autelitano ir@irtop.com | ||
Paolo Cimminoir@farmacosmo.it | farmacosmo@illimity.com | |
Domenico Gentile | ||
ufficiostampa@irtop.com |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Farmacosmo S.p.A. published this content on 18 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 May 2023 18:20:25 UTC.
